Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
7.51
-0.07 (-0.92%)
At close: Mar 18, 2026, 4:00 PM EDT
7.75
+0.24 (3.20%)
After-hours: Mar 18, 2026, 7:19 PM EDT

Eupraxia Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
80.5633.119.3418.2616.51
Short-Term Investments
----7.12
Cash & Short-Term Investments
80.5633.119.3418.2623.63
Cash Growth
143.39%71.14%5.91%-22.70%19954.27%
Other Receivables
0.670.230.190.090.34
Receivables
0.670.230.190.090.34
Prepaid Expenses
3.861.110.270.240.21
Total Current Assets
85.134.4419.818.5924.18
Property, Plant & Equipment
0.990.420.460.530.47
Other Long-Term Assets
0.060.080.0100.02
Total Assets
86.1534.9420.2719.1224.67
Accrued Expenses
5.513.013.872.911.67
Current Portion of Long-Term Debt
--10.40.080.08
Current Portion of Leases
0.080.070.050.050.05
Current Income Taxes Payable
0-0.04--
Other Current Liabilities
0.040.025.020.020
Total Current Liabilities
5.633.119.373.061.79
Long-Term Debt
---8.87.66
Long-Term Leases
0.08--0.050.11
Total Liabilities
5.73.119.3711.919.56
Common Stock
195.41116.3692.917161.36
Additional Paid-In Capital
28.5220.517.5116.85-
Retained Earnings
-169.58-131-105.5-77.28-58.68
Comprehensive Income & Other
-2.04-4.16-2.71-2.7913.09
Total Common Equity
52.31.72.227.7915.77
Minority Interest
-1.6-1.57-1.32-0.58-0.66
Shareholders' Equity
80.4531.840.897.2115.11
Total Liabilities & Equity
86.1534.9420.2719.1224.67
Total Debt
0.150.0710.458.997.9
Net Cash (Debt)
80.4133.038.899.2815.73
Net Cash Growth
143.45%271.55%-4.18%-41.03%-
Net Cash Per Share
2.010.970.370.481.27
Filing Date Shares Outstanding
61.535.8535.6227.3614.24
Total Common Shares Outstanding
51.9435.6427.2821.5914.24
Working Capital
79.4731.330.4315.5322.39
Book Value Per Share
1.010.050.080.361.11
Tangible Book Value
52.31.72.227.7915.77
Tangible Book Value Per Share
1.010.050.080.361.11
Buildings
----0.07
Machinery
1.350.70.680.610.1
Leasehold Improvements
0.130.120.130.130.13
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q